Cargando…
Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line
BACKGROUND: The aminoisoquinoline FX-9 shows pro-apoptotic and antimitotic effects against lymphoblastic leukemia cells and prostate adenocarcinoma cells. In contrast, decreased cytotoxic effects against non-neoplastic blood cells, chondrocytes, and fibroblasts were observed. However, the actual FX-...
Autores principales: | Weiner, F., Schille, J. T., Koczan, D., Wu, X.-F., Beller, M., Junghanss, C., Hewicker-Trautwein, M., Murua Escobar, H., Nolte, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501574/ https://www.ncbi.nlm.nih.gov/pubmed/34625047 http://dx.doi.org/10.1186/s12885-021-08836-y |
Ejemplares similares
-
Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines
por: Weiner, Franziska, et al.
Publicado: (2021) -
Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines
por: Schille, Jan Torben, et al.
Publicado: (2019) -
Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis
por: Packeiser, Eva-Maria, et al.
Publicado: (2020) -
TiHo-0906: a new feline mammary cancer cell line with molecular, morphological, and immunocytological characteristics of epithelial to mesenchymal transition
por: Granados-Soler, José Luis, et al.
Publicado: (2018) -
An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes
por: Thiemeyer, Heike, et al.
Publicado: (2021)